Area of research
Molecular Biology · Rheumatology
Research interest
Research interests include Porphyrin Metabolism and Disorders, Heme Oxygenase-1 and Carbon Monoxide, Folate and B Vitamins Research, and Neonatal Health and Biochemistry.
Long-term follow-up of givosiran treatment in patients with acute intermittent porphyria from a phase 1/2, 48-month open-label extension study
Risk of primary liver cancer in acute hepatic porphyria patients: A matched cohort study of 1244 individuals
Hyperhomocysteinemia in acute hepatic porphyria (AHP) and implications for treatment with givosiran
Integration of whole genome sequencing into a healthcare setting: high diagnostic rates across multiple clinical entities in 3219 rare disease patients
Efficacy and safety of givosiran for acute hepatic porphyria: 24‐month interim analysis of the randomized phase 3 ENVISION study
Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria
Phase 1 Trial of an RNA Interference Therapy for Acute Intermittent Porphyria
EXPLORE: A Prospective, Multinational, Natural History Study of Patients with Acute Hepatic Porphyria with Recurrent Attacks
Recurrent attacks of acute hepatic porphyria: major role of the chronic inflammatory response in the liver
High risk of primary liver cancer in a cohort of 179 patients with Acute Hepatic Porphyria